Avicanna (AVCNF, $0.19) was a top loser over the last three months, falling -2 to $0.19 per share. A.I.dvisor analyzed 204 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending June 5, 2025, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.